Forecast for the Home Health Industry
2021 was a historically hot year for M&A transactions, and we don’t expect that momentum to cool. Perhaps the biggest factor in this sustained trajectory is buy-side demand, which remains as strong as ever.
While some point to rising interest rates, inflation, and stressors on the employment and supply chain landscapes as reasons why both valuations and overall activity may cool, we remain convinced that the abundance of capital and exuberance of investors will provide a counterbalance to sustain these levels of activity.
For more insight into our outlook, download this report to unlock the factors we expect to significantly impact M&A activity, both across the general market and within the home health industry.